NP47924 Cytokine Modulators

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1K-£44M
Sector
HEALTH
Published
19 Mar 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 13 suppliers

1 buyer

9 suppliers

Description

Supply of Cytokine Modulators to NHS Scotland.

Lot Division

1 Etanercept

Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
2 Infliximab IV

Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.
3 Infliximab SC

Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.
4 Methotrexate syringes (25mg/1 ml concentration)

Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
5 Methotrexate pens (25mg/1ml concentration)

Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
6 Methotrexate pens (50mg/1 ml concentration)

Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
7 Methotrexate syringes (50mg/1ml concentration)

Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Award Detail

1 Biogen Idec (Maidenhead)
  • Etanercept
  • Reference: 010054-2025-1
  • Value: £1,700,000 [share]
  • Awarded to group of suppliers.
2 Sandoz (Surrey)
  • Etanercept
  • Reference: 010054-2025-1
  • Value: £1,700,000 [share]
  • Awarded to group of suppliers.
3 Pfizer (Tadworth)
  • Etanercept
  • Reference: 010054-2025-1
  • Value: £1,700,000 [share]
  • Awarded to group of suppliers.
4 Celltrion Healthcare (Slough)
  • Infliximab IV
  • Reference: 010054-2025-2
  • Value: £44,300,000 [share]
  • Awarded to group of suppliers.
5 Janssen Cilag (High Wycombe)
  • Infliximab IV
  • Reference: 010054-2025-2
  • Value: £44,300,000 [share]
  • Awarded to group of suppliers.
6 Biogen Idec (Maidenhead)
  • Infliximab IV
  • Reference: 010054-2025-2
  • Value: £44,300,000 [share]
  • Awarded to group of suppliers.
7 Sandoz (Camberley)
  • Infliximab IV
  • Reference: 010054-2025-2
  • Value: £44,300,000 [share]
  • Awarded to group of suppliers.
8 Accord Healthcare (North Harrow)
  • Methotrexate pens (25mg/1ml concentration)
  • Reference: 010054-2025-3
  • Value: £5,150,000 [share]
  • Awarded to group of suppliers.
9 Medac Pharma (Stirling)
  • Methotrexate pens (25mg/1ml concentration)
  • Reference: 010054-2025-3
  • Value: £5,150,000 [share]
  • Awarded to group of suppliers.
10 Celltrion Healthcare (Slough)
  • Infliximab SC
  • Reference: 010054-2025-4
  • Value: £4,200,000
11 Accord Healthcare (North Harrow)
  • Methotrexate syringes (25mg/1 ml concentration)
  • Reference: 010054-2025-5
  • Value: £577,000
12 Nordic Pharma (Reading)
  • Methotrexate pens (50mg/1 ml concentration)
  • Reference: 010054-2025-6
  • Value: £1,000
13 Nordic Pharma (Reading)
  • Methotrexate syringes (50mg/1ml concentration)
  • Reference: 010054-2025-7
  • Value: £15,000

Award Criteria

API Sources 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:793130)

Reference

Domains